← FDA DRUG APPROVALS

FDA NDA · NDA019714

AMINOSYN II 5% W/ ELECTROLYTES IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER

Sponsor: ABBOTT

APPLICATION
NDA019714
TYPE
NDA
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

AMINOSYN II 5% W/ ELECTROLYTES IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINERDiscontinued
AMINO ACIDS 5%, CALCIUM CHLORIDE 36.8MG/100ML, DEXTROSE 25GM/100ML, MAGNESIUM CHLORIDE 51MG/100ML, POTASSIUM CHLORIDE 22.4MG/100ML, POTASSIUM PHOSPHATE, DIBASIC 261MG/100ML, SODIUM CHLORIDE 205MG/100ML · INJECTABLE · INJECTION
AMINOSYN II 3.5% W/ ELECTROLYTES IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINERDiscontinued
AMINO ACIDS 3.5%, CALCIUM CHLORIDE 36.8MG/100ML, DEXTROSE 25GM/100ML, MAGNESIUM CHLORIDE 51MG/100ML, POTASSIUM CHLORIDE 22.4MG/100ML, POTASSIUM PHOSPHATE, DIBASIC 261MG/100ML, SODIUM CHLORIDE 205MG/100ML · INJECTABLE · INJECTION
AMINOSYN II 4.25% W/ ELECTROLYTES IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINERDiscontinued
AMINO ACIDS 4.25%, CALCIUM CHLORIDE 36.8MG/100ML, DEXTROSE 25GM/100ML, MAGNESIUM CHLORIDE 51MG/100ML, POTASSIUM CHLORIDE 22.4MG/100ML, POTASSIUM PHOSPHATE, DIBASIC 261MG/100ML, SODIUM CHLORIDE 205MG/100ML · INJECTABLE · INJECTION
AMINOSYN II 4.25% W/ ELECTROLYTES IN DEXTROSE 20% W/ CALCIUM IN PLASTIC CONTAINERDiscontinued
AMINO ACIDS 4.25%, CALCIUM CHLORIDE 36.8MG/100ML, DEXTROSE 20GM/100ML, MAGNESIUM CHLORIDE 51MG/100ML, POTASSIUM CHLORIDE 22.4MG/100ML, POTASSIUM PHOSPHATE, DIBASIC 261MG/100ML, SODIUM CHLORIDE 205MG/100ML · INJECTABLE · INJECTION
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →